If after a few months you are already 1/2 way to your goal, then you probably didn't have a lot of weight to lose, so I think that it's important to put that into context, especially since others may read this thread who have substantially more weight to lose and are just starting out.
To provide the counterpoint to low and slow, which I believe you are asking about, if people have significant amounts of weight to lose (which doesn't necessarily seem to apply to you), there appears to be a "window of opportunity" after which weight loss on glp-1 medications tends to slow and plateau (12 to 16 months). Switching to another medication or stacking might break that stall, but that's an entire separate conversation.
So, for morbidly obese individuals, low and slow might not be the most effective strategy given the aforementioned window of opportunity. I think that the medical community has revised it's guidance on dose titration since the tirzepatide clinical studies to recongize that if a patient is losing weight consistently and having good hunger suppression that there is no need to titrate up. But, if a patient is not losing weight or is suffering from food noise, and is tolerating the current dose, that dose escalation makes sense.
My fear for people who have a lot of weight to lose, is that they somehow perceive that low and slow is "better" and "less cheating" and forego the full benefits of treatment and then don't reach the weight loss goals they could have if they had taken a more aggressive (if they can tolerate it) dose escalation regime.